Lakefront Biotherapeutics repurchases 132,014 shares under June buyback program
AI Summary- Lakefront Biotherapeutics repurchased 132,014 ordinary shares through an independent financial intermediary.
- €3,279,463.42 was paid at an average €24.84 per share from August 31 to September 4.
- Lakefront held 1,293,338 own ordinary shares at market close September 4, 2026.